单孔胸腔镜肺段切除术治疗早期NSCLC患者肺功能及无瘤生存期的影响

Abstract
Figure/Table
References
Related Citation (7)

Download: PDF (1952 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the effect of single-port thoracoscopic segmentectomy on lung function, serum trauma response and long-term metastasis in patients with early non-small cell lung cancer (NSCLC). Methods 200 patients with early NSCLC admitted to our hospital from April 2020 to September 2021 were divided into the control group (100 cases) and observation group (100 cases) by using a computer to randomly generate numbers. The control group received single-port thoracoscopic lobectomy while the observation group patients recceived single-port thoracoscopic segmentectomy. The surgical conditions of the two groups was compared, including lung function [forced vital capacity (FVC), forced expiratory volume in one second (FEV1) and FEV1/FVC ratio], serum trauma response indicators [prostaglandin (PGE2), cortisol (Cor) and C-reactive protein (CRP) ] and tumor cell carcinoembryonic antigen (CEA), cytokeratin 19 fragment (CYFRA21-1) and squamous cell carcinoma antigen (SCC-Ag). The survival and long-term metastasis were tested by Kaplan-Meier curve, and the complications were compared. Results Compared with control group, the intraoperative blood loss in observation group was less and the surgical duration was shorter, but the number of lymph nodes dissection was not significantly different between the two groups. At 3 months after surgery, the lung function parameters FVC, FEV1 and FEV1/FVC in both groups were significantly decreased compared with those before surgery, but the decreases were relatively small in observation group, which had significant differences compared to control group. Serum levels of PGE2, Cor and CRP in the two groups at 1 month after surgery were significantly increased compared with those before surgery, but the increases in observation group were relatively small compared with those in control group. The levels of CEA, CYFRA21-1 and SCC-Ag in both groups was significantly reduced compared to before surgery, and the levels in observation group were lower than those in control group. At 2 years after surgery, metastasis was less in the two groups, and there was no significant difference in disease-free survival between the two groups. In addition, the complications revealed no obvious differences between the two groups. Conclusion Compared with lobectomy, single-port thoracoscopic segmentectomy in the treatment of NSCLC can better relieve the trauma response, maintain the lung function, and reduce the risk of tumor recurrence and metastasis.

Key words： single-port thoracoscopic segmentectomy non-small cell lung cancer lung function disease free survival

Received: 11 October 2023

PACS:

R734.2

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	XI Lei
	SHI Ye
	CUI Weiming
	CAO Hui

Cite this article:

XI Lei,SHI Ye,CUI Weiming等. Effect of single-port thoracoscopic segmentectomy on lung function, and disease free survival in patients with early NSCLC[J]. HuNan ShiFan DaXue XueBao(YiXueBan), 2023, 20(6): 108-112.

URL:

http://yxb.hunnu.edu.cn/EN/ OR http://yxb.hunnu.edu.cn/EN/Y2023/V20/I6/108

[1] 刘彦军. 早期非小细胞肺癌患者经单孔全胸腔镜解剖性肺段切除术治疗疗效评价[J]. 中国药物与临床, 2021, 21(11): 1921-1923.
[2] 万仁平, 廖洪亮, 易云峰. 完全胸腔镜下解剖性肺段切除与肺叶切除对非小细胞癌患者术后肺功能的影响[J]. 河北医药, 2018, 40(11): 1609-1612.
[3] 周跃, 袁双虎. 非小细胞肺癌纵隔淋巴结分期诊断研究进展[J]. 中华肿瘤防治杂志, 2017, 24(5): 344-349.
[4] LABABEDE O, MEZIANE MA.The Eighth Edition of TNM Staging of Lung Cancer: Reference Chart and Diagrams[J]. Oncologist, 2018, 23(7): 844-848.
[5] 张睿娟, 雷弋. 早期肺腺癌临床病理特征及分子特征研究进展[J]. 现代肿瘤医学, 2021, 29(23): 4246-4250.
[6] 梁启军, 杨玉萍, 李存霞. 非小细胞肺癌发病机制及中西医结合治疗路径再探析[J]. 中华中医药杂志, 2012, 27(5): 1355-1357.
[7] 李传俊, 罗燕, 吴晓涛, 等. 周围型非小细胞肺癌CT特征与EGFR基因突变的相关性研究[J]. 中国CT和MRI杂志, 2018, 16(8): 46-49.
[8] 王君, 张天赐, 魏大中. 单孔胸腔镜肺段切除术治疗肺结节118例[J]. 中国微创外科杂志, 2020, 20(11): 991-994.
[9] 张亚年, 张璐, 范心庭. 胸腔镜肺段切除术治疗非小细胞肺癌的临床效果及其对血清LDH、ProGRP、NSE的影响[J]. 临床和实验医学杂志, 2022, 21(19): 2062-2066.
[10] Zhang L.The Argument and Consensus of Lymphadenectomy on Lung Cancer Surgery[J]. Zhongguo Fei Ai Za Zhi, 2018, 21(3): 176-179.
[11] 李威, 郑中锋, 游锦智, 等. 不同入路单孔3D胸腔镜在Ⅰ-Ⅱ期非小细胞肺癌切除术中应用效果的对比研究[J]. 现代肿瘤医学, 2023, 31(1): 66-70.
[12] 田浩印, 李志娜, 李静, 等. 术前肺功能、术后sTREM-1、小野寺指数诊断NSCLC患者术后肺部感染的价值[J]. 标记免疫分析与临床, 2023, 30(2): 298-303.
[13] 马朝峰. 培美曲塞联合顺铂化疗对晚期非小细胞肺癌患者血清肿瘤标志物及KPS评分的影响[J]. 罕少疾病杂志, 2022, 29(4): 30-31.
[14] 杨宠裕. 瑞芬太尼复合丙泊酚麻醉对非小细胞肺癌根治术患者免疫功能及术后瞻妄的影响[J]. 医学临床研究, 2021, 38(3): 421-423+427.
[15] HAO C, ZHANG G, ZHANG L.Serum CEA levels in 49 different types of cancer and noncancer diseases[J]. Prog Mol Biol Transl Sci, 2019, 162: 213-227.
[16] DAL BELLO MG, FILIBERTI RA, ALAMA A, et al.The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients[J]. J Transl Med, 2019, 17(1): 74-78.
[17] ZHU B, DONG B, HONG S, et al.Combined Detection of ACTN4 and SCC-Ag is a Promising Serological Biomarker for Cervical Intraepithelial Neoplasia 3 or Worse: A Case-Control Study[J]. Risk Manag Healthc Policy, 2020, 13: 2677-2687.
[18] 方妙婵, 钟孟如, 张泳仪, 等. CRP、PCT、NC及NLR在非小细胞肺癌化疗后细菌感染诊断中的价值[J]. 川北医学院学报, 2023, 38(1): 32-35.
[19] 宋立强, 崔昊, 梁文全, 等. 早期胃癌伴淋巴结转移患者远期预后的影响因素分析[J]. 腹腔镜外科杂志, 2023, 28(1): 41-45.